RSSCategory: Laboratory Compliance

Webinar: Primary Diagnosis with Digital Pathology Systems and Whole Slide Images: What Every Pathologist Needs to Know, Why It Will Be Disruptive, and How Innovative Pathology Groups Are Already Making Money with DP

| August 4, 2017 | 0 Comments

Live Webinar Event Thursday, August 17th, 2017 at 1pm EDT Speedy adoption of digital pathology systems and WSI can give your pathology group considerable competitive advantage. It can mean stronger relationships with referring physicians, more case referrals, expanded market share, increased revenue, and greater pathologist compensation for you and your colleagues. In these financially-stressful times, […]

Continue Reading

Inspirata Marks 1st Anniversary of 10-Year Engagement at Ohio State’s James Cancer Hospital and Solove Research Institute with Behind-the-Scenes Look at the Groundbreaking Digital Pathology Project

| July 26, 2017 | 0 Comments

Inspirata will be offering a behind-the-scenes look at its work with the cancer hospital during a Corporate Workshop it is hosting on Thursday, July 27th from 3:00 – 4:30 at the Association of Pathology Chairs (APC) Annual Meeting this week in Washington, DC. Washington, DC, July 26, 2017 – Cancer diagnostics and pathology workflow solution provider […]

Continue Reading

FDA Approval of Immunotherapy For MSI-High or Mismatch Repair Deficient Tumors

| June 5, 2017 | 0 Comments

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have progressed following prior treatment. KEYTRUDA has also been approved fro MSI-H or dMMR colorectal cancers that have progressed following treatment with conventional chemotherapies. The immunooncology/immunotherapy story is fascinating. […]

Continue Reading

Inspirata to Participate in Thought Leadership for Cancer Information Sharing at the Association for Pathology Informatics Annual Summit in Pittsburgh May 22-25

| May 22, 2017 | 0 Comments

Inspirata will showcase its Cancer Diagnostic Cockpit and Consultation Portal as well as present scientific findings on a system that mines relevant information in cancer case reports. Pittsburgh, PA, May 22, 2017 – Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today that it is exhibiting in booth B2 at the Association for […]

Continue Reading

Leica Biosystems Applauds FDA Primary Diagnosis Clearance as a Step Forward in Clinical Acceptance of Digital Pathology

| May 11, 2017 | 0 Comments

VISTA, CA – May 11, 2017 – The digital pathology industry just took another step forward, with the FDA clearance of a whole slide imaging (WSI) system (Philips IntelliSite™ Pathology Solution) for review of digital surgical pathology slides. Leica Biosystems congratulates both the FDA and the Digital Pathology Association (DPA) on this positive outcome from […]

Continue Reading

162 Days of Change

| April 17, 2017 | 1 Comment

As of last Thursday, April 12, 2017 and going back to a rainy night in Cleveland on November 2, 2016, the past 162 days have seen at least 3 things most Americans, and perhaps many across the world thought they would never see happen in their lifetimes. That rainy night in Cleveland started the clock […]

Continue Reading

Will Not Using Image Analysis in Pathology be Perceived as Irresponsible? 

| February 1, 2017 | 0 Comments

Originally published by Simon Häger, Product Manager Sectra Digital Pathology Solution at Sectra.com.  It is hard to argue with any of the points raised here by Simon. No doubt image analysis will enable what we do to do it better. More quantitative analysis. Better, faster, cheaper, more accurate. Image analysis and tele-consultation have been and will […]

Continue Reading

Understanding Reimbursement Changes in the U.S. and What They Mean to Your Anatomic Pathology (AP) Laboratory

| January 24, 2017 | 0 Comments

Save your spot to learn more about the effects of reimbursement changes in the US on the anatomic pathology market and in your laboratory You are invited to our next complimentary webinar – January 24, 2017 Understanding Reimbursement Changes in the U.S. and What They Mean to Your Anatomic Pathology (AP) Laboratory The United States […]

Continue Reading

PRESS RELEASE: Innovative Anatomic Pathology Groups Use New Strategies to Increase Revenue and Maximize Pathologists’ Income Despite Unprecedented Price Cuts, Exclusionary Narrow Networks and Tougher Payer Audits

| January 23, 2017 | 0 Comments

PRESS RELEASE   THE DARK REPORT 21806 Briarcliff Dr. Spicewood, Texas 78669 512-264-7103 o 512-264-0969 f   FOR IMMEDIATE RELEASE Media Contact: Chris Garcia chris@darkreport.com   AUSTIN, Texas (January 16, 2017) It is the worst financial environment for the anatomic pathology profession in decades. Across the nation, pathology groups are coping with falling revenue, rising […]

Continue Reading

Register Now for CAP Webinar on HER2 Testing in Gastroesophageal Adenocarcinoma

| January 13, 2017 | 0 Comments

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive advanced GEA. Because there are important differences in HER2 expression, scoring, and outcomes in GEA relative to breast carcinoma, the need for guideline recommendations […]

Continue Reading

To Sign Out or Not to Sign Out? Part 2: The Fax Machine

| January 13, 2017 | 0 Comments

I received a lot of feedback offline about Part 1 of this post (see: “To Sign Out or Not to Sign Out? Part 1” ) from a number of pathologists echoing my sentiments on the issue of turnaround time in general and needs/expectations from clinicians and patients about getting their results in a timely manner. […]

Continue Reading

To Sign Out or Not to Sign Out? Part 1

| December 27, 2016 | 0 Comments

That is the question. Every year. Around the holidays or three-day weekends. Normally biopsies or surgical specimens collected the day before are reviewed the next day. In a majority of cases, the case can be “signed out” meaning your opinion goes into a surgical pathology report and becomes part of the medical record. New malignancies, […]

Continue Reading

FDA Delays Final Guidance on Regulating LDTs

| November 25, 2016 | 0 Comments

medpagetoday.com posted a brief but concise article earlier this week on the issue of FDA regulating laboratory developed tests (LDTs). While the FDA has had the ability to regulate these tests since 1976, largely once regarded as “simple and scarce” as the article mentions, not before a draft guidance issued in 2014 has the FDA […]

Continue Reading

Mikroscan and QualityStar® Partner To Address Subspecialty Case Review In Community Pathology Practices

| October 25, 2016 | 0 Comments

Enabling Economical Digital Pathology Transformation for Next-gen Diagnostic Accuracy in AP San Diego, CA — October 25, 2016 — Mikroscan Technologies, Inc. Mikroscan announced today it has entered into an agreement with QualityStar, LLC., a quality analytics and case review subscription service for Anatomic Pathology, to market its cloud-based and confidential case review to help […]

Continue Reading